Financials Meta Biomed Co., Ltd.

Equities

A059210

KR7059210005

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
3,970 KRW -0.38% Intraday chart for Meta Biomed Co., Ltd. -7.35% -8.94%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 68,950 64,799 64,352 66,184 52,832 99,718
Enterprise Value (EV) 1 94,000 95,169 93,216 84,746 77,763 127,356
P/E ratio -59.5 x 19.4 x -15.8 x 6.95 x 20.1 x 9.89 x
Yield 0.34% 0.36% 0.36% 0.69% 0.87% 0.46%
Capitalization / Revenue 1.08 x 1.09 x 1.36 x 1.13 x 0.77 x 1.2 x
EV / Revenue 1.47 x 1.6 x 1.97 x 1.44 x 1.13 x 1.53 x
EV / EBITDA -145 x 10.1 x 16.1 x 9.6 x 8.46 x 8.59 x
EV / FCF -7.07 x -22.8 x 65.6 x 15 x -12.6 x -38.2 x
FCF Yield -14.1% -4.39% 1.52% 6.67% -7.96% -2.62%
Price to Book 1.37 x 1.22 x 1.34 x 1.13 x 0.87 x 1.42 x
Nbr of stocks (in thousands) 23,492 23,267 22,901 22,901 22,871 22,871
Reference price 2 2,935 2,785 2,810 2,890 2,310 4,360
Announcement Date 3/20/19 3/18/20 3/17/21 3/18/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 63,813 59,391 47,209 58,780 68,942 83,101
EBITDA 1 -649 9,466 5,790 8,832 9,196 14,825
EBIT 1 -4,080 5,753 1,848 5,261 5,336 10,602
Operating Margin -6.39% 9.69% 3.91% 8.95% 7.74% 12.76%
Earnings before Tax (EBT) 1 616.8 5,925 -4,619 7,584 3,988 7,805
Net income 1 -1,148 3,346 -4,093 9,522 2,628 10,080
Net margin -1.8% 5.63% -8.67% 16.2% 3.81% 12.13%
EPS 2 -49.30 143.4 -178.0 415.8 114.8 440.7
Free Cash Flow 1 -13,290 -4,182 1,420 5,650 -6,193 -3,338
FCF margin -20.83% -7.04% 3.01% 9.61% -8.98% -4.02%
FCF Conversion (EBITDA) - - 24.53% 63.97% - -
FCF Conversion (Net income) - - - 59.34% - -
Dividend per Share 2 10.00 10.00 10.00 20.00 20.00 20.00
Announcement Date 3/20/19 3/18/20 3/17/21 3/18/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 25,050 30,370 28,864 18,562 24,931 27,638
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -38.59 x 3.208 x 4.986 x 2.102 x 2.711 x 1.864 x
Free Cash Flow 1 -13,290 -4,182 1,420 5,650 -6,193 -3,338
ROE (net income / shareholders' equity) -2.25% 10.8% -7.84% 17.4% 5.83% 14.7%
ROA (Net income/ Total Assets) -2.35% 3.58% 1.09% 3.12% 2.97% 5.28%
Assets 1 48,929 93,528 -374,138 305,471 88,331 191,065
Book Value Per Share 2 2,142 2,289 2,095 2,547 2,649 3,063
Cash Flow per Share 2 235.0 101.0 377.0 442.0 578.0 472.0
Capex 1 9,081 7,561 2,227 2,067 15,395 11,489
Capex / Sales 14.23% 12.73% 4.72% 3.52% 22.33% 13.83%
Announcement Date 3/20/19 3/18/20 3/17/21 3/18/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A059210 Stock
  4. Financials Meta Biomed Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW